Limit search to available items
Book Cover
E-book

Title Metabolic effects of psychotropic drugs / volume editors, J. Thakore, B.E. Leonard
Published Basel ; New York : Karger, 2009

Copies

Description 1 online resource (viii, 133 pages) : illustrations
Series Modern trends in pharmacopsychiatry, 1662-2685 ; v. 26
Modern trends in pharmacopsychiatry ; v. 26.
Contents Metabolic syndrome and schizophrenia : is inflammation the cause? / Leonard, B.E. -- Insulin resistance in bipolar women : effects of mood-stabilizing drugs / Vemuri, M. [and others] -- Obesity and mental illness / Citrome, L., Vreeland, B. -- Glucose abnormalities in schizophrenia, bipolar, and major depressive disorders / Bushe, C. -- Screening for diabetes and cardiovascular risk factors in people with serious mental illness / Holt, R.I.G., Peveler, R.C. -- Stress axis dysfunction : a common finding in schizophrenia and the metabolic syndrome? / Afzal, A., Thakore, J. -- Metabolic syndrome in psychiatric inpatients treated for depression / Goethe, J.W., Szarek, B.L., Caley, C.F. -- Hyperprolactinaemia associated with antipsychotic medications / Fitzgerald, P., Dinan, T.G. -- Impact of hyperprolactinaemia on the general health of patients with schizophrenia / Wildgust, H.J., Kohen, D
Summary Major depression and bipolar disorder are chronic enduring serious mental illnesses (SMI) with devastating effects on psychosocial functioning and may culminate in suicide. Over the past years, it has become apparent that subjects with these conditions can also develop the metabolic syndrome, which is a series of obesity-related physical conditions with an endocrine basis. This book brings together reviews that help put into context exactly why subjects with SMI develop obesity, prediabetic status, overt type 2 diabetes mellitus and related cardiovascular events. The relationship between prolactin and bone mineral density in subjects under medical treatment and the underlying dopaminergic mechanisms as well as the immunological changes occurring as an integral part of SMI and their effects on endocrine function are discussed and reviewed. Psychiatrists, diabetologists, cardiologists, family practitioners, public health physicians as well as basic science researchers will find valuable guidelines when screening for type 2 diabetes mellitus and cardiovascular disease in SMI
Bibliography Includes bibliographical references and index
Notes Print version record
Subject Psychotropic drugs -- Side effects.
Metabolic syndrome.
Schizophrenia -- Chemotherapy -- Complications
Psychotropic Drugs -- adverse effects
Psychotropic Drugs -- metabolism
Metabolic Syndrome
Mental Disorders -- drug therapy
MEDICAL -- Pain Medicine.
MEDICAL -- Psychiatry -- Psychopharmacology.
Metabolic syndrome
Psychotropic drugs -- Side effects
Psychopharmakon -- Metabolisches Syndrom.
Metabolisches Syndrom -- Psychopharmakon.
Form Electronic book
Author Thakore, Jogin H., 1962-
Leonard, B. E
S. Karger (Firm)
ISBN 9783805590020
3805590024
1283153394
9781283153393
3805590016
9783805590013